TE_144
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2 |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | FAM131C |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.77 |
| Counts of samples | TCGA_tumor:212; TCGA_normal:44; GTEx:267 |
| TSS | chr1(-):16064069 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_144.1 | FAM131C | Chimeric | Non-coding | Non-coding | chr1(-):16058697,16058717,16059494,16059604,16059869,16060051,16062099,16062192,16062499,16062534,16063521,16063636,16064024,16064070 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
